These effects, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a unique solution to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar disorders. Research on conolidine is proscribed, https://codyokcsj.blogitright.com/26949622/conolidine-secrets